Close Menu

NEW YORK (GenomeWeb) – Waters today announced that it will establish a joint open laboratory with the Chinese Pharmacopoeia Commission.

The lab, which will be located in the Beijing Zhendong Guangming Drug Research Institute, is slated to open by the end of the year. Activities there will be directed at research into pharmacopoeia standards, developing testing methods, validating the methods, and providing training in pharmacopoeia detection methods. The lab, the partners said, is anticipated to become a national technical support center in Chinese pharmaceutical standards.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.